Sleep, Light, Circadian, Central Oxidative Stress

Many people in modern society sleep at irregular times and get less sleep than their bodies need, yet the biological reasons why this harms the brain are not fully understood. This upcoming clinical trial at Brigham and Women's Hospital plans to investigate two specific mechanisms: first, whether the timing of sleep is misaligned with the body's internal ~24-hour clock (circadian misalignment), and second, whether insufficient or mistimed sleep increases oxidative stress in the brain. Oxidative stress refers to a buildup of chemically reactive molecules that can damage cells, including neurons. The researchers hypothesize that both of these pathways independently or jointly contribute to the cognitive impairment and increased risk of neurodegenerative disease associated with poor sleep habits. By experimentally probing these mechanisms, the study aims to identify precise biological targets that could be addressed by future interventions. The trial is not yet recruiting as of mid-2026, so no results are available. If successful, findings could reshape how clinicians think about sleep irregularity — not just sleep duration — as a modifiable risk factor for brain health.

• No results are available — the trial is listed as NOT_YET_RECRUITING with an anticipated start date of 2026-05-26; all findings below are projected research aims, not outcomes.
• The primary investigative targets are circadian misalignment (desynchrony between behavioural sleep timing and the endogenous ~24-hour biological clock) and brain oxidative stress as dual mechanistic pathways linking irregular or insufficient sleep to cognitive decline.
• The study is designed to inform the development of future interventions aimed at mitigating sleep-loss-related harm to cognition and long-term brain health, suggesting an eventual translational or therapeutic application phase.

This is a prospective interventional or observational clinical trial registered on ClinicalTrials.gov (NCT07471126), sponsored by Brigham and Women's Hospital. The protocol is designed to experimentally manipulate or measure circadian alignment and oxidative stress markers in the context of irregular or insufficient sleep; specific sample size, intervention arms, and follow-up duration are not disclosed in the available abstract. Given the institution's established circadian research infrastructure, the trial likely involves controlled inpatient or outpatient sleep-scheduling protocols with biological sampling (e.g., melatonin assays for circadian phase, biofluid or neuroimaging markers of oxidative stress). All methodological details are best-effort inferences from the abstract and should be treated as low-confidence pending protocol publication.

Because the trial has not yet begun recruiting, no efficacy, safety, or mechanistic data exist, and the entire evidence contribution is prospective and speculative at this stage. The abstract does not specify sample size, blinding strategy, or how brain oxidative stress will be measured in humans — a non-trivial methodological challenge given that direct neural sampling is invasive. Circadian misalignment protocols (e.g., forced desynchrony) are logistically demanding and may limit ecological validity or generalisability to real-world irregular sleepers. A critical next experiment would be a dose-response design establishing the minimum degree of circadian misalignment sufficient to elevate oxidative stress biomarkers, and whether correcting timing alone (without extending sleep duration) reverses those markers.

This trial sits at the mechanistic core of the corpus's circadian-cognition thread, extending [§97] (a population-based lighting study in older adults) by moving from epidemiological light-exposure associations to controlled investigation of the intracellular consequences — oxidative stress — of circadian disruption. It closely parallels [§33] (the TREAD time-restricted eating trial for Alzheimer's disease), which similarly tests whether realigning circadian biology through behavioural timing can protect the aging brain, though TREAD uses dietary timing rather than sleep scheduling as its lever. The dual-pathway framework (circadian misalignment plus oxidative stress) also contextualises [§44], which characterises the CLOCK-BMAL1 molecular complex as a therapeutic target, providing a plausible upstream molecular mechanism for the oxidative stress signatures this trial intends to measure. Compared with [§96], which documents cognitive impairment in elderly veterans with sleep-disordered breathing, this trial investigates analogous cognitive outcomes but through circadian and redox pathways rather than respiratory ones, highlighting that multiple distinct sleep-disruption mechanisms may converge on similar neurocognitive endpoints. Given that no results are yet available, confidence in precise corpus positioning is flagged as low and should be revisited upon protocol or results publication.

• Population Based Lighting Study on Older Adults
  Direct mechanistic complement: where this trial examines intracellular oxidative stress responses to circadian disruption, [id=97] examines how real-world light environments drive circadian disruption at the population level in a similar older-adult demographic.
• TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
  Closest design analogue in the corpus — TREAD also tests whether correcting circadian timing (via meal scheduling) protects cognition and brain health in a neurodegenerative-risk population, enabling direct comparison of dietary vs. sleep-timing interventions.
• The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting
  Provides the molecular scaffolding (CLOCK-BMAL1 structure and dysfunction) that would explain how circadian misalignment mechanistically produces the oxidative stress this trial aims to measure, bridging basic science to clinical readout.
• Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
  Parallel cognitive-impairment endpoint in a sleep-disrupted population, but driven by obstructive respiratory pathology rather than circadian misalignment — comparing results could disentangle hypoxic from circadian contributions to neurocognitive decline.
• dlmoR: An open-source R package for the dim-light melatonin onset (DLMO) hockey-stick method
  Methodological resource: the dlmoR package for dim-light melatonin onset quantification offers the most common circadian-phase biomarker this trial is likely to employ, making [id=31] a direct methods-comparison reference for circadian assessment validity.